CN109824553B - 2–((叔丁氧基羰基)氨基)乙基-1-磺酸及其制备方法 - Google Patents
2–((叔丁氧基羰基)氨基)乙基-1-磺酸及其制备方法 Download PDFInfo
- Publication number
- CN109824553B CN109824553B CN201910298391.2A CN201910298391A CN109824553B CN 109824553 B CN109824553 B CN 109824553B CN 201910298391 A CN201910298391 A CN 201910298391A CN 109824553 B CN109824553 B CN 109824553B
- Authority
- CN
- China
- Prior art keywords
- tert
- amino
- butoxycarbonyl
- ethyl
- sulfonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- -1 (tert-butoxycarbonyl) amino Chemical group 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 71
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 claims abstract description 64
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims abstract description 50
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 48
- 229960003080 taurine Drugs 0.000 claims abstract description 34
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims abstract description 30
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims abstract description 15
- 235000017557 sodium bicarbonate Nutrition 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000003054 catalyst Substances 0.000 claims abstract description 4
- 239000002904 solvent Substances 0.000 claims abstract description 4
- 239000011259 mixed solution Substances 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 239000005457 ice water Substances 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 8
- 238000004440 column chromatography Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000002390 rotary evaporation Methods 0.000 claims description 3
- 238000003889 chemical engineering Methods 0.000 abstract description 2
- 239000012847 fine chemical Substances 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract description 2
- 239000000376 reactant Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical compound Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 229930182852 proteinogenic amino acid Natural products 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910298391.2A CN109824553B (zh) | 2019-04-15 | 2019-04-15 | 2–((叔丁氧基羰基)氨基)乙基-1-磺酸及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910298391.2A CN109824553B (zh) | 2019-04-15 | 2019-04-15 | 2–((叔丁氧基羰基)氨基)乙基-1-磺酸及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109824553A CN109824553A (zh) | 2019-05-31 |
CN109824553B true CN109824553B (zh) | 2021-08-13 |
Family
ID=66875183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910298391.2A Expired - Fee Related CN109824553B (zh) | 2019-04-15 | 2019-04-15 | 2–((叔丁氧基羰基)氨基)乙基-1-磺酸及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109824553B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115232036A (zh) * | 2022-07-21 | 2022-10-25 | 南通大学 | 一种二苯乙烯多酚牛磺酸酯、制备方法及其用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101270099A (zh) * | 2007-03-19 | 2008-09-24 | 代斌 | N-[2-(1-乙氧酰基-3-苯丙氨基)-牛磺酰基]-噻唑烷酸及其衍生物制备方法 |
CN102603666A (zh) * | 2012-02-28 | 2012-07-25 | 石河子大学 | 肉桂酰牛磺酰噻唑烷酸类化合物及其应用 |
CN103772463A (zh) * | 2013-12-30 | 2014-05-07 | 郑州大学 | 2-甲氧基雌二醇类似物及其制备方法与用途 |
CN104478798A (zh) * | 2014-12-18 | 2015-04-01 | 武汉华纳联合药业有限公司 | N-氨基烷基磺酰基-3-吡啶甲酰胺衍生物及其在制备治疗心脑血管病药物中的应用 |
-
2019
- 2019-04-15 CN CN201910298391.2A patent/CN109824553B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101270099A (zh) * | 2007-03-19 | 2008-09-24 | 代斌 | N-[2-(1-乙氧酰基-3-苯丙氨基)-牛磺酰基]-噻唑烷酸及其衍生物制备方法 |
CN102603666A (zh) * | 2012-02-28 | 2012-07-25 | 石河子大学 | 肉桂酰牛磺酰噻唑烷酸类化合物及其应用 |
CN103772463A (zh) * | 2013-12-30 | 2014-05-07 | 郑州大学 | 2-甲氧基雌二醇类似物及其制备方法与用途 |
CN104478798A (zh) * | 2014-12-18 | 2015-04-01 | 武汉华纳联合药业有限公司 | N-氨基烷基磺酰基-3-吡啶甲酰胺衍生物及其在制备治疗心脑血管病药物中的应用 |
Non-Patent Citations (2)
Title |
---|
"Helical Antimicrobial Sulfono-γ-AApeptides";Li Yaqiong等;《J. Med. Chem.》;20150528;第58卷;Figure S2 * |
"mt-tRNA COMPONENTS: SYNTHESIS OF (2-THIO)URIDINES MODIFIED WITH BLOCKED GLYCINE/TAURINE MOIETIES AT C-5,1";Grazyna Leszczynska等;《Nucleosides, Nucleotides and N ucleic Acids》;20131018;第32卷;Scheme 2, 第606页第1段 * |
Also Published As
Publication number | Publication date |
---|---|
CN109824553A (zh) | 2019-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115772107B (zh) | 一种硫亚胺酯\酰胺的制备方法 | |
CN112062712A (zh) | 一种2-(5-溴-3-甲基吡啶-2-基)乙酸盐酸盐的制备方法 | |
CN107501112A (zh) | 一种手性β‑氨基酸的手性合成方法及医药中间体的合成方法 | |
CN109824553B (zh) | 2–((叔丁氧基羰基)氨基)乙基-1-磺酸及其制备方法 | |
CN111909078A (zh) | 一种(2-氟-6-(三氟甲基)吡啶-3-基)甲醇的合成方法 | |
EP2247573B1 (en) | Carbonic and sulphuric acid salts of 3-(2,2,2-trimethylhydrazinium)propionate esters and their use for 3-(2,2,2-trimethylhydrazinium)propionate dihydrate preparation | |
CN111943854B (zh) | 一种3,4-二氯-2-硝基苯甲酸的合成方法 | |
CN106699604B (zh) | 一种沙库比曲及其中间体的制备方法 | |
CN114716382B (zh) | 一种抗新冠药物Ensitrelvir中间体的连续流合成工艺 | |
CN110922409A (zh) | 制备btk抑制剂泽布替尼的方法 | |
CN113735750A (zh) | 一种室温下nbs参与制备s-取代基-半胱氨酸衍生物的方法 | |
JP2018039773A (ja) | 含窒素9員環アルキン | |
CN112174832A (zh) | 一种一步合成5-氯-2-甲基-4-(三氟甲基)苯胺的方法 | |
CN106748884B (zh) | 一种比卡鲁胺中间体的制备方法 | |
CN111662233B (zh) | 一种一步法合成4-氯-1h-咪唑-2-羧酸乙酯的方法 | |
CN109134204A (zh) | 中间体2-溴-4-氟-5-氯苯酚的合成法 | |
JP2022029051A (ja) | チオエステル誘導体の製造方法 | |
CN114853756B (zh) | 化合物Tomivosertib的制备工艺 | |
CN114057668B (zh) | 一种氨基保护基手性2-氨基-3-(4-吗啉基苯基)丙酸的合成方法 | |
CN114539106B (zh) | 一种稳定同位素标记的牛磺酰胺盐酸盐的合成方法 | |
CN113024521B (zh) | 一种制备恩曲替尼的方法 | |
JP2022029068A (ja) | チオエステル誘導体の製造方法 | |
US11661661B2 (en) | Method for synthesizing beta-cyano ketone compound | |
CN112624968B (zh) | 一种5-氨基-3-氰基吡啶甲酸甲酯盐酸盐的合成方法 | |
CN107129437A (zh) | 4-[(2-氯乙基-2-羟乙基)氨基-]-l-苯丙氨酸盐酸盐的制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Zhizhong Inventor after: Yan Chunhua Inventor after: Tian Bingren Inventor after: Huang Qing Inventor after: Ma Peipei Inventor after: Quan Hongfeng Inventor after: Wei Shijie Inventor before: Yan Chunhua Inventor before: Tian Bingren Inventor before: Huang Qing Inventor before: Ma Peipei Inventor before: Quan Hongfeng Inventor before: Wei Shijie Inventor before: Wang Zhizhong |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210813 |